Issue Date: July 3, 2017
BASF invests big in ibuprofen
BASF will spend about $225 million to increase its capacity for the bulk analgesic ibuprofen. The company says it will expand its existing facility in Bishop, Texas, next year and build a new facility by 2021 at its headquarters in Ludwigshafen, Germany. BASF says the new plant will be Europe’s first large ibuprofen facility. The firm claims to have a unique, eco-efficient manufacturing process.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society